{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:46:05Z","timestamp":1785930365940,"version":"3.56.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Glutarimide-containing Cereblon (CRBN) ligands are critical motifs for PROTACs, molecular glue degraders and next-generation Cereblon E3 ligase modulatory drugs (CELMoDs), which represent promising therapeutic modalities in targeted protein degradation. However, the multistep synthetic routes required to access glutarimide scaffolds continue to present formidable challenges for medicinal chemists, limiting rapid structure\u2013activity relationship (SAR) exploration and late-stage diversification. To streamline access to these privileged motifs, modular and efficient methodologies are still highly desirable. Here, we report a unified organocatalytic synthesis platform for the rapid assembly of diverse glutarimide derivatives from readily available nitrogen heterocycles. Employing a sequence of phosphine-catalysed C\u2013N bond formation, metal-free Giese addition and acid-mediated cyclisation, this approach provides high selectivity, broad functional group tolerance and operational simplicity under conditions amenable to both multigram synthesis and high-throughput parallel synthesis. Using this platform, we rapidly prepare CRBN binder libraries, access control analogues (for example,\n                    <jats:italic>N<\/jats:italic>\n                    \u2011alkylated glutarimides) and perform late\u2011stage functionalisation of bioactive molecules. This strategy could offer a transformative solution for the efficient and cost-effective synthesis of CRBN-targeted therapeutics and chemical biology probes, overcoming longstanding synthetic bottlenecks in the field.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-74673-x","type":"journal-article","created":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T07:47:27Z","timestamp":1782028047000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A unified platform for the rapid assembly of glutarimides for Cereblon E3 ligase modulatory drugs"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5988-7457","authenticated-orcid":false,"given":"David M.","family":"Whalley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4191-4522","authenticated-orcid":false,"given":"Olivier","family":"Lorthioir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8403-9698","authenticated-orcid":false,"given":"Niall A.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Braybrooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3590-9113","authenticated-orcid":false,"given":"Susannah C.","family":"Coote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4533-6280","authenticated-orcid":false,"given":"Sylvain","family":"Demanze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly L.","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6968-1858","authenticated-orcid":false,"given":"Okky Dwichandra","family":"Putra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Proctor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Staniland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Stokes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfie","family":"Woodhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,21]]},"reference":[{"key":"74673_CR1","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/s41589-019-0362-y","volume":"15","author":"PP Chamberlain","year":"2019","unstructured":"Chamberlain, P. P. & Hamann, L. G. Development of targeted protein degradation therapeutics. Nat. Chem. Biol. 15, 937\u2013944 (2019).","journal-title":"Nat. Chem. Biol."},{"key":"74673_CR2","doi-asserted-by":"publisher","first-page":"5214","DOI":"10.1039\/D2CS00193D","volume":"51","author":"K Li","year":"2022","unstructured":"Li, K. & Crews, C. M. PROTACs: past, present and future. Chem. Soc. Rev. 51, 5214\u20135236 (2022).","journal-title":"Chem. Soc. Rev."},{"key":"74673_CR3","doi-asserted-by":"publisher","first-page":"6234","DOI":"10.1039\/D2CS00116K","volume":"51","author":"J Yamamoto","year":"2022","unstructured":"Yamamoto, J., Ito, T., Yamaguchi, Y. & Handa, H. Discovery of CRBN as a target of thalidomide: a breakthrough for progress in the development of protein degraders. Chem. Soc. Rev. 51, 6234\u20136250 (2022).","journal-title":"Chem. Soc. Rev."},{"key":"74673_CR4","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1126\/science.add7574","volume":"378","author":"ER Watson","year":"2022","unstructured":"Watson, E. R. et al. Molecular glue CELMoD compounds are regulators of cereblon conformation. Science 378, 549\u2013553 (2022).","journal-title":"Science"},{"key":"74673_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","volume":"21","author":"M Bekes","year":"2022","unstructured":"Bekes, M., Langley, D. R. & Crews, C. M. PROTAC targeted protein degraders: the past is prologue. Nat. Rev. Drug Discov. 21, 181\u2013200 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"74673_CR6","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1039\/D2CS00148A","volume":"51","author":"I Sosi\u010d","year":"2022","unstructured":"Sosi\u010d, I., Bricelj, A. & Steinebach, C. E3 ligase ligand chemistries: from building blocks to protein degraders. Chem. Soc. Rev. 51, 3487\u20133534 (2022).","journal-title":"Chem. Soc. Rev."},{"key":"74673_CR7","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nsmb.2874","volume":"21","author":"PP Chamberlain","year":"2014","unstructured":"Chamberlain, P. P. et al. Structure of the human Cereblon-DDB1-lenalidomide complex reveals basis for responsiveness to thalidomide analogs. Nat. Struct. Mol. Biol. 21, 803\u2013809 (2014).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"74673_CR8","doi-asserted-by":"crossref","unstructured":"Rodrigo-Brenni, M. C. et al. A dihydrouracil CRBN ligand mitigates IMiD associated safety liabilities in heterobifunctional targeted protein degrader. Nat. Commun. 17, 4460 (2026).","DOI":"10.1038\/s41467-026-70663-1"},{"key":"74673_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70401","volume":"6","author":"G Fan","year":"2025","unstructured":"Fan, G. et al. Proteolysis-targeting chimera (PROTAC): current applications and future directions. MedComm 6, e70401 (2025).","journal-title":"MedComm"},{"key":"74673_CR10","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1021\/acsmedchemlett.5c00308","volume":"16","author":"LH Jones","year":"2025","unstructured":"Jones, L. H. Property-based optimization of cereblon-based molecular glue degraders. ACS Med. Chem. Lett. 16, 1456\u20131462 (2025).","journal-title":"ACS Med. Chem. Lett."},{"key":"74673_CR11","doi-asserted-by":"publisher","first-page":"18022","DOI":"10.1021\/acs.jmedchem.4c01305","volume":"67","author":"X Zheng","year":"2024","unstructured":"Zheng, X. et al. Discovery of KT-474\u2500a potent, selective, and orally bioavailable IRAK4 degrader for the treatment of autoimmune diseases. J. Med. Chem. 67, 18022\u201318037 (2024).","journal-title":"J. Med. Chem."},{"key":"74673_CR12","doi-asserted-by":"publisher","first-page":"16237","DOI":"10.1021\/acs.jmedchem.5c01086","volume":"68","author":"T Wei","year":"2025","unstructured":"Wei, T. et al. Discovery of novel potent triple IKZF1\/2\/3 degraders for the treatment of hematological cancers. J. Med. Chem. 68, 16237\u201316259 (2025).","journal-title":"J. Med. Chem."},{"key":"74673_CR13","doi-asserted-by":"publisher","first-page":"9584","DOI":"10.1021\/acs.jmedchem.5c00358","volume":"68","author":"A Srivastava","year":"2025","unstructured":"Srivastava, A., Pike, A., Swedrowska, M., Nash, S. & Grime, K. In vitro ADME profiling of PROTACs: successes, challenges, and lessons learned from analysis of clinical PROTACs from a diverse physicochemical space. J. Med. Chem. 68, 9584\u20139593 (2025).","journal-title":"J. Med. Chem."},{"key":"74673_CR14","doi-asserted-by":"publisher","first-page":"11732","DOI":"10.1021\/acs.jmedchem.4c00269","volume":"67","author":"SK Bagal","year":"2024","unstructured":"Bagal, S. K. et al. Discovery of a series of orally bioavailable androgen receptor degraders for the treatment of prostate cancer. J. Med. Chem. 67, 11732\u201311750 (2024).","journal-title":"J. Med. Chem."},{"key":"74673_CR15","doi-asserted-by":"publisher","first-page":"18230","DOI":"10.1021\/acs.jmedchem.5c00668","volume":"68","author":"X Zhang","year":"2025","unstructured":"Zhang, X. et al. Discovery of a novel series of iso-indolinone-based glutarimides as highly efficacious and selective IKZF2 molecular glue degraders. J. Med. Chem. 68, 18230\u201318257 (2025).","journal-title":"J. Med. Chem."},{"key":"74673_CR16","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1055\/s-0043-1775385","volume":"56","author":"C Nilewski","year":"2024","unstructured":"Nilewski, C., Villemure, E., Wang, Y., Zhou, Y. & Wong, A. R. Tactics and strategies for the synthesis of cereblon ligands. Synthesis 56, 3543\u20133554 (2024).","journal-title":"Synthesis"},{"key":"74673_CR17","doi-asserted-by":"publisher","first-page":"18301","DOI":"10.1021\/acs.joc.4c02136","volume":"89","author":"IDG Nixon","year":"2024","unstructured":"Nixon, I. D. G. et al. One-step regioselective synthesis of N-1-substituted dihydrouracils: a motif of growing popularity in the targeted protein degradation field. J. Org. Chem. 89, 18301\u201318312 (2024).","journal-title":"J. Org. Chem."},{"key":"74673_CR18","doi-asserted-by":"publisher","first-page":"17738","DOI":"10.1021\/acs.joc.4c02536","volume":"89","author":"JW Gu","year":"2024","unstructured":"Gu, J. W. et al. Expedited aminoglutarimide C\u2013N cross-coupling enabled by high-throughput experimentation. J. Org. Chem. 89, 17738\u201317743 (2024).","journal-title":"J. Org. Chem."},{"key":"74673_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202319856","volume":"63","author":"P Neigenfind","year":"2024","unstructured":"Neigenfind, P. et al. Simplifying access to targeted protein degraders via nickel electrocatalytic cross-coupling. Angew. Chem. Int. Ed. 63, e202319856 (2024).","journal-title":"Angew. Chem. Int. Ed."},{"key":"74673_CR20","doi-asserted-by":"publisher","first-page":"29523","DOI":"10.1021\/jacs.4c09327","volume":"146","author":"LM Chen","year":"2024","unstructured":"Chen, L. M. et al. Ni-catalyzed asymmetric reductive arylation of alpha-substituted imides. J. Am. Chem. Soc. 146, 29523\u201329530 (2024).","journal-title":"J. Am. Chem. Soc."},{"key":"74673_CR21","doi-asserted-by":"publisher","first-page":"16388","DOI":"10.1021\/acs.jmedchem.3c01848","volume":"66","author":"S Norris","year":"2023","unstructured":"Norris, S. et al. Design and synthesis of novel cereblon binders for use in targeted protein degradation. J. Med. Chem. 66, 16388\u201316409 (2023).","journal-title":"J. Med. Chem."},{"key":"74673_CR22","unstructured":"Hideaki, K. et al. Preparation of 3-phenylpropylamine derivatives having SF-1 antagonist activity. WO2025070690A1 (2025)."},{"key":"74673_CR23","doi-asserted-by":"publisher","first-page":"6648","DOI":"10.1021\/acs.jmedchem.9b01928","volume":"63","author":"JD Hansen","year":"2020","unstructured":"Hansen, J. D. et al. Discovery of CRBN E3 Ligase Modulator CC-92480 for the treatment of relapsed and refractory multiple myeloma. J. Med. Chem. 63, 6648\u20136676 (2020).","journal-title":"J. Med. Chem."},{"key":"74673_CR24","doi-asserted-by":"publisher","first-page":"7595","DOI":"10.1021\/ja971238z","volume":"119","author":"BM Trost","year":"1997","unstructured":"Trost, B. M. & Dake, G. R. Nucleophilic \u03b1-addition to alkynoates. A synthesis of dehydroamino acids. J. Am. Chem. Soc. 119, 7595\u20137596 (1997).","journal-title":"J. Am. Chem. Soc."},{"key":"74673_CR25","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1080\/10426500214574","volume":"177","author":"I Yavari","year":"2002","unstructured":"Yavari, I. & Bayat, M. Triphenylphosphine-catalyzed simple synthesis of vinyl-substituted saccharins. Phosphorus Sulfur Silicon Relat. Elem. 177, 2537\u20132545 (2002).","journal-title":"Phosphorus Sulfur Silicon Relat. Elem."},{"key":"74673_CR26","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1016\/j.tet.2005.01.038","volume":"61","author":"M Han\u00e9danian","year":"2005","unstructured":"Han\u00e9danian, M., Loreau, O., Sawicki, M. & Taran, F. Tributylphosphine as a superior catalyst for the \u03b1-C-addition of 1,3-dicarbonyl compounds to electron-deficient alkynes. Tetrahedron 61, 2287\u20132294 (2005).","journal-title":"Tetrahedron"},{"key":"74673_CR27","doi-asserted-by":"publisher","first-page":"10250","DOI":"10.1021\/acs.joc.2c01231","volume":"87","author":"JD Ellefsen","year":"2022","unstructured":"Ellefsen, J. D. & Miller, S. J. Photocatalytic reductive olefin hydrodifluoroalkylation enabled by tertiary amine reductants compatible with complex systems. J. Org. Chem. 87, 10250\u201310255 (2022).","journal-title":"J. Org. Chem."},{"key":"74673_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1021\/acs.oprd.3c00314","volume":"28","author":"MJ Zacuto","year":"2024","unstructured":"Zacuto, M. J. et al. Chirality control in the kilogram-scale manufacture of single-enantiomer CELMoDs: synthesis of iberdomide\u00b7BSA, Part 2. Org. Process Res. Dev. 28, 57\u201366 (2024).","journal-title":"Org. Process Res. Dev."},{"key":"74673_CR29","unstructured":"Packer, M. J. et al. Compounds and their use in treating cancer. WO2023\/139199 (2023)."},{"key":"74673_CR30","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1126\/science.aba2419","volume":"367","author":"T Constantin","year":"2020","unstructured":"Constantin, T. et al. Aminoalkyl radicals as halogen-atom transfer agents for activation of alkyl and aryl halides. Science 367, 1021\u20131026 (2020).","journal-title":"Science"},{"key":"74673_CR31","doi-asserted-by":"publisher","first-page":"11326","DOI":"10.1021\/acs.jmedchem.4c00883","volume":"67","author":"H Duan","year":"2024","unstructured":"Duan, H. et al. Discovery of a highly potent and selective BRD9 PROTAC degrader based on E3 Binder investigation for the treatment of hematological tumors. J. Med. Chem. 67, 11326\u201311353 (2024).","journal-title":"J. Med. Chem."},{"key":"74673_CR32","doi-asserted-by":"publisher","first-page":"8586","DOI":"10.1021\/acs.orglett.5c02505","volume":"27","author":"D Zell","year":"2025","unstructured":"Zell, D. et al. Stereoselective synthesis of trans-3-Amino-2,2,4,4-tetramethylcyclobutanol. Org. Lett. 27, 8586\u20138590 (2025).","journal-title":"Org. Lett."},{"key":"74673_CR33","unstructured":"Mainolfi, N., JI, N., Zhang, Y. & Weiss, M. M. Crbn ligands and uses thereof. WO2019\/140387 (2019)."},{"key":"74673_CR34","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1021\/acs.oprd.9b00276","volume":"23","author":"Q Yang","year":"2019","unstructured":"Yang, Q. et al. Explosion hazards of sodium hydride in dimethyl sulfoxide, N,N-dimethylformamide, and N,N-dimethylacetamide. Org. Process Res. Dev. 23, 2210\u20132217 (2019).","journal-title":"Org. Process Res. Dev."},{"key":"74673_CR35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.chembiol.2023.02.005","volume":"30","author":"S Bonazzi","year":"2023","unstructured":"Bonazzi, S. et al. Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy. Cell Chem. Biol. 30, 235\u2013247 e212 (2023).","journal-title":"Cell Chem. Biol."},{"key":"74673_CR36","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1021\/acs.jmedchem.4c01787","volume":"68","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. et al. Design and discovery of preclinical candidate LYG-409 as a highly potent and selective GSPT1 molecular glue degraders. J. Med Chem. 68, 2608\u20132638 (2025).","journal-title":"J. Med Chem."},{"key":"74673_CR37","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1021\/acs.jmedchem.0c01489","volume":"64","author":"JD Hansen","year":"2021","unstructured":"Hansen, J. D. et al. CC-90009: a cereblon E3 ligase modulating drug that promotes selective degradation of GSPT1 for the treatment of acute myeloid leukemia. J. Med. Chem. 64, 1835\u20131843 (2021).","journal-title":"J. Med. Chem."},{"key":"74673_CR38","doi-asserted-by":"crossref","unstructured":"Ataollahi, E., Sadeghpour, H., Zamani, L. & Khabnadideh, S. An improved procedure for synthesis of lenalidomide as an active pharmaceutical ingredient. Results Chem. 17, 102625 (2025).","DOI":"10.1016\/j.rechem.2025.102625"},{"key":"74673_CR39","unstructured":"Fitzgerald, M. E., Hird, A. W., Henderson, J. A. & Vora, H. U. Protein tyrosine phosphatase degraders and methods of use thereof. WO2021127586A1 (2021)."},{"key":"74673_CR40","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1021\/acs.oprd.6b00108","volume":"20","author":"F Yang","year":"2016","unstructured":"Yang, F. et al. A facile route of synthesis for making flibanserin. Org. Process Res. Dev. 20, 1576\u20131580 (2016).","journal-title":"Org. Process Res. Dev."},{"key":"74673_CR41","first-page":"221","volume":"52","author":"LA Opler","year":"1991","unstructured":"Opler, L. A. & Feinberg, S. S. The role of pimozide in clinical psychiatry: a review. J. Clin. Psychiatry 52, 221\u2013233 (1991).","journal-title":"J. Clin. Psychiatry"},{"key":"74673_CR42","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1021\/jm00355a011","volume":"26","author":"AB Foster","year":"1983","unstructured":"Foster, A. B., Jarman, M., Leung, C. S., Rowlands, M. G. & Taylor, G. N. Analogs of aminoglutethimide: selective inhibition of cholesterol side-chain cleavage. J. Med. Chem. 26, 50\u201354 (1983).","journal-title":"J. Med. Chem."},{"key":"74673_CR43","doi-asserted-by":"crossref","unstructured":"Lysenko, V. et al. Multigram Synthesis of 3-Azabicyclo[3.1.1]heptane Derivatives Including Bicyclic Thalidomide Analogs. Eur. J. Organic Chem. 28, 938 (2025).","DOI":"10.1002\/ejoc.202400938"},{"key":"74673_CR44","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/(SICI)1521-4184(199801)331:1<7::AID-ARDP7>3.0.CO;2-N","volume":"331","author":"U Teubert","year":"1998","unstructured":"Teubert, U., Zwingenberger, K., Wnendt, S. & Eger, K. 5\u2032-substituted thalidomide analogs as modulators of TNF-\u03b1. Arch. Pharm. 331, 7\u201312 (1998).","journal-title":"Arch. Pharm."},{"key":"74673_CR45","doi-asserted-by":"publisher","first-page":"14513","DOI":"10.1021\/acs.jmedchem.3c00851","volume":"66","author":"C Steinebach","year":"2023","unstructured":"Steinebach, C. et al. Leveraging ligand affinity and properties: discovery of novel benzamide-type cereblon binders for the design of PROTACs. J. Med. Chem. 66, 14513\u201314543 (2023).","journal-title":"J. Med. Chem."},{"key":"74673_CR46","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1055\/s-0033-1351044","volume":"79","author":"B Ndunda","year":"2013","unstructured":"Ndunda, B., Langat, M. K., Wanjohi, J. M., Midiwo, J. O. & Kerubo, L. O. Alienusolin, a New 4\u03b1-deoxyphorbol ester derivative, and crotonimide C, a new glutarimide alkaloid from the kenyan croton alienus. Planta Med. 79, 1762\u20131766 (2013).","journal-title":"Planta Med."},{"key":"74673_CR47","unstructured":"Omura, S. S., Kazuro; Mori, Mihoko; Matsumoto, Atsuko; Suzuki, Yasuhiko; Nakajima, Chie; Yamaguchi, Tomoyuki. Novel k95-5901-1 substance and method for producing same. WO2019189331 (2019)."},{"key":"74673_CR48","unstructured":"Crew, A. P. et al. Cereblon ligands and bifunctional compounds comprising the same. WO2018144649A1 (2018)."},{"key":"74673_CR49","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1021\/acs.jmedchem.6b01781","volume":"61","author":"RP Wurz","year":"2018","unstructured":"Wurz, R. P. et al. A \u201cClick Chemistry Platform\u201d for the rapid synthesis of bispecific molecules for inducing protein degradation. J. Med. Chem. 61, 453\u2013461 (2018).","journal-title":"J. Med. Chem."},{"key":"74673_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202500929","volume":"21","author":"A Maksutova","year":"2026","unstructured":"Maksutova, A. et al. A facile protocol for C(sp2)\u2013C(sp3) bond formation reactions toward functionalized E3 ligase ligands. ChemMedChem 21, e202500929 (2026).","journal-title":"ChemMedChem"},{"key":"74673_CR51","doi-asserted-by":"publisher","first-page":"19564","DOI":"10.1039\/D4SC06684G","volume":"15","author":"DM Whalley","year":"2024","unstructured":"Whalley, D. M. et al. Merging nucleophilic phosphine catalysis and photocatalysis for the rapid assembly of 2-oxabicyclo-[2.1.1]hexane scaffolds from feedstock allyl alcohols. Chem. Sci. 15, 19564\u201319570 (2024).","journal-title":"Chem. Sci."},{"key":"74673_CR52","doi-asserted-by":"publisher","first-page":"31433","DOI":"10.1021\/jacs.4c06127","volume":"146","author":"H Razumkov","year":"2024","unstructured":"Razumkov, H. et al. Discovery of CRBN-dependent WEE1 molecular glue degraders from a multicomponent combinatorial library. J. Am. Chem. Soc. 146, 31433\u201331443 (2024).","journal-title":"J. Am. Chem. Soc."},{"key":"74673_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43614-3","volume":"14","author":"Z Wang","year":"2023","unstructured":"Wang, Z. et al. Direct-to-biology, automated, nano-scale synthesis, and phenotypic screening-enabled E3 ligase modulator discovery. Nat. Commun. 14, 8437 (2023).","journal-title":"Nat. Commun."},{"key":"74673_CR54","doi-asserted-by":"publisher","first-page":"16939","DOI":"10.1021\/acs.jmedchem.3c01613","volume":"66","author":"CM Arndt","year":"2023","unstructured":"Arndt, C. M. et al. One-pot synthesis of cereblon proteolysis targeting chimeras via photoinduced C(sp2)\u2013C(sp3) cross coupling and amide formation for proteolysis targeting chimera library synthesis. J. Med. Chem. 66, 16939\u201316952 (2023).","journal-title":"J. Med. Chem."},{"key":"74673_CR55","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1039\/D4MD00760C","volume":"16","author":"R Stevens","year":"2025","unstructured":"Stevens, R. et al. Expanding the reaction toolbox for nanoscale direct-to-biology PROTAC synthesis and biological evaluation. RSC Med. Chem. 16, 1141\u20131150 (2025).","journal-title":"RSC Med. Chem."},{"key":"74673_CR56","doi-asserted-by":"publisher","first-page":"15282","DOI":"10.1021\/acs.jmedchem.2c01218","volume":"65","author":"IP Bhela","year":"2022","unstructured":"Bhela, I. P. et al. A versatile and sustainable multicomponent platform for the synthesis of protein degraders: proof-of-concept application to BRD4-degrading PROTACs. J. Med. Chem. 65, 15282\u201315299 (2022).","journal-title":"J. Med. Chem."},{"key":"74673_CR57","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1021\/acs.joc.4c02456","volume":"90","author":"R Stevens","year":"2025","unstructured":"Stevens, R., Palmer, H. E. P., Miah, A. H. & Burley, G. A. Factors to consider for synthesis in 1536-well plates\u2500an amide coupling case study for PROTAC synthesis. J. Org. Chem. 90, 2192\u20132200 (2025).","journal-title":"J. Org. Chem."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74673-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74673-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74673-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:03:39Z","timestamp":1785927819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74673-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,21]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["74673"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-74673-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.26434\/chemrxiv-2026-qdrsf","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,21]]},"assertion":[{"value":"11 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"7812"}}